GlassScriptPhysician profile
Linda Som
NPI 1477511764
$7,133.21
in general payments reported to CMS, 2019-2025
41 companies · $740 in 2025
The $740 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $1,049 · 2021: $1,421 · 2022: $991 · 2023: $1,267 · 2024: $896 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,903.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,277.30 | 2019-2025 | Mavyret, Ubrelvy, Viberzi |
| Gilead Sciences, INC. | $1,211.95 | 2019-2025 | Vemlidy |
| Glaxosmithkline, LLC. | $351.83 | 2019-2024 | Arexvy |
| Lilly USA, LLC | $297.88 | 2019-2023 | Emgality, Jardiance |
| Astrazeneca Pharmaceuticals LP | $259.52 | 2019-2021 | |
| Pfizer INC. | $258.80 | 2019-2025 | |
| Lucid Diagnostics INC. | $208.94 | 2022-2024 | |
| Biohaven Pharmaceuticals, INC. | $196.30 | 2020-2021 | |
| Redhill Biopharma INC. | $178.29 | 2020-2022 | |
| Abbott Laboratories | $161.47 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.77 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $155.94 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $146.82 | 2019-2025 | |
| Hologic Sales and Service, LLC | $138.84 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Amgen INC. | $129.34 | 2021-2025 | Otezla, Repatha, Repatha |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $96.42 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.09 | 2025 | Lifevest |
| Allergan, INC. | $83.38 | 2019-2020 | |
| Abiomed | $74.52 | 2023 | Impella |
| Cleerly, INC. | $64.40 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Merck Sharp & Dohme LLC | $55.42 | 2019-2025 | Gardasil 9, Capvaxive |
| Agios Pharmaceuticals, INC. | $47.54 | 2024-2025 | Pyrukynd |
| Boston Scientific Corporation | $46.69 | 2020-2022 | |
| Braeburn INC. | $44.64 | 2025 | Brixadi |
| Amarin Pharma, INC. | $44.05 | 2020-2021 | |
| Indivior INC. | $39.10 | 2025 | Sublocade |
| Exact Sciences Corporation | $38.99 | 2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $33.45 | 2021-2022 | |
| Oxford Immunotec USA INC | $28.60 | 2022 | |
| Phadia US INC. | $26.71 | 2020-2025 | Immunocap |
| Csl Behring | $25.25 | 2019 | |
| Teleflex LLC | $22.84 | 2023 | Urolift |
| Aimmune Therapeutics, INC. | $22.31 | 2025 | Zenpep |
| Ultragenyx Pharmaceutical INC. | $18.44 | 2019 | |
| Medtronic, INC. | $18.04 | 2021 | |
| Tactile Systems Technology INC | $16.91 | 2019 | |
| Seqirus USA INC | $13.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.84 | 2022 | |
| Optos, INC. | $13.31 | 2021 | |
| Neurocrine Biosciences, INC. | $13.30 | 2022 | |
| Sonex Health, INC. | $12.07 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Som listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.